Figure 1 Lymphocytes during the disease

Slides:



Advertisements
Similar presentations
Rheumatoid Arthritis(RA)
Advertisements

Part B Autoimmune Diseases Part B Autoimmune Diseases Effector mechanisms of autoimmune disease Endocrine glands as special targets.
AUTOIMMUNITY. Self/Non-self Discrimination Autoimmunity is a problem of self/non-self discrimination.
Tissue Repair and Tissue Disorders. Replacing old/worn out tissue New cells generate by mitosis from the stroma (supporting connective tissue) or the.
Physiological Diseases of the human Skeleton. Inflammatory Disorders of joints Joint pain and discomfort can be caused by many factors Bursitis Arthritis.
R HEUMATOID F ACTOR ( RF ). Rheumatoid arthritis is a chronic inflammatory disorder that affects all joints either in hands or feet and other areas of.
Acute Inflammation (recruitment of neutrophils).
AUTOIMMUNITY AND AUTOIMMUNE DISEASE
Failures against ‘self’ (Principles of Autoimmunity)
Cellular components in RA joints Synovial membrane with synovial lining cells Cartilage Joint capsule Inflamed, thick synovial membrane Invading.
Figure 1 Role of innate lymphoid cells (ILCs) in steady state,
AUTOIMMUNE DISEASES.
Nat. Rev. Rheumatol. doi: /nrrheum
of different experimental arthritis models
Figure 3 The adaptive and maladaptive energy matrices
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Example of how a noncoding regulatory rheumatoid
Figure 3 Connexins in cartilage
Figure 1 Historical evolution of the clinical classification and
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Clinical and microbiological aspects of periodontitis
Figure 1 Enthesitis versus synovitis
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Induction of immune tolerance
Figure 4 Ex vivo synovial tissue culture viability
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Transcriptome studies performed in the target
Figure 2 Shared genetic loci in systemic autoimmune diseases
Figure 1 Location of HLA variants known to be associated
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Strategies to achieve therapeutic inhibition of IL-1
Figure 2 Type 3 immunity and AS
Figure 2 Interaction effects between heterozygous HLA‑DRB1
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Statistical approaches for the analysis of metabolomic data
Figure 6 Lack of IRF5 causes a reduction in neutrophil influx
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 5 The role of Ly6Chi and Ly6Clo monocytes
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Multi-hit model for autoimmune diseases
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Emerging hallmarks of T cells in rheumatoid arthritis
Autoimmunity through Cytokine-Induced Dendritic Cell Activation
Figure 1 Treat to target, remission and low disease activity in SLE
Figure 1 The current model of the pathogenesis of SLE
Figure 6 Metabolism of pterins
Figure 1 Principles for the diagnosis and management of osteoarthritis
Figure 2 GM-CSF — a key player in inflammation and autoimmunity
Figure 2 Embryonic origins of tissue-resident macrophages
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Chronic inflammation and DNA damage in people with SLE
Figure 2 Phenotypes of osteoarthritis
Figure 1 Differential effects of bone-forming agents on bone surfaces
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Patterns of joint and organ involvement in rheumatic disease
Figure 4 Role of chemokines in dendritic cell migration
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 The role of macrophages in RA
Figure 2 Involvement of plasmacytoid dendritic cells
Presentation transcript:

Figure 1 Lymphocytes during the disease process of rheumatoid arthritis in different tissue environments Figure 1 | Lymphocytes during the disease process of rheumatoid arthritis in different tissue environments. The disease process of rheumatoid arthritis (RA) involves multiple tissue environments and extends over several decades. An early event is the breakdown of immunologic tolerance, which occurs in lymphoid tissues. After expansion and maturation of autoreactive lymphocytes, autoantigens are encountered in peripheral tissues, eventually leading to the formation of tertiary lymphoid microstructures and chronic destructive inflammation. The inflamed synovial membrane and the disrupted tissue repair response represent the end stage of RA. Weyand, C. M. & Goronzy, J. J. (2017) Immunometabolism in early and late stages of rheumatoid arthritis Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.49